PREVENT Vitiligo study : combination approach with epidermal cell suspension and topical ruxolitinib cream for difficult to treat areas.
(expected winter 2022-23)
In 2023: new clinical trials with oral JAK inhibitors for widespread
and/or active vitiligos
In 2023: new topical treatment for localized vitiligos.